Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10362/73622| Título: | Adenovirus as a Biopharmaceutical |
| Outros títulos: | Optimisation of vector production |
| Autor: | Ferreira, Tiago Bruno Pereira Soares |
| Orientador: | Alves, Paula Marques Carrondo, Manuel José Teixeira |
| Palavras-chave: | Adenovirus Biopharmaceutical |
| Data de Defesa: | 2007 |
| Resumo: | "Adenovirus vectors (AdV) have attracted considerable interest over the past decade, with ongoing clinical development programs for applications ranging from replacement therapy for protein deficiencies to cancer therapeutics to prophylactic vaccines. In fact, in the period 1989-2005, over 300 clinical trials were conducted using adenoviruses worldwide, adenovirus type 5 (Ad5) being the vector of choice. Consequently, considerable product process, analytical and formulation development has to be carried out in order to respond to the constantly increasing market requirements for AdV.(...)" |
| URI: | http://hdl.handle.net/10362/73622 |
| Designação: | Dissertation presented to obtain the PhD degree in Chemical Engineering |
| Aparece nas colecções: | ITQB: CBL - PhD Theses |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| Adenovirus as a Biopharmaceutical - Optimisation of vector production by Tiago Bruno Ferreira.pdf | 3,3 MB | Adobe PDF | Ver/Abrir |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.
